Amneal Pharmaceuticals, Inc. (AMRX)

Last Three Months

29-Jan-24 -- 28-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

29

0

4

+1

0

+2

0

+3

Two Year Chart

29-Apr-22 -- 28-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
05-Mar-24 4:40 PM View:	03-Mar-24 Payment of Exercise ($243.75K)	Boyer Andrew S Executive Vice President		Amneal Pharmaceuticals, Inc. - AMRX	30% 244.74K to 319.38K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:35 PM View:	03-Mar-24 Payment of Exercise ($225.01K)	Shah Nikita Executive Vice President		Amneal Pharmaceuticals, Inc. - AMRX	22% 319.97K to 391.67K	0	0	--	--	Show Txns Hide Txns

14-Mar-24 4:17 PM View:	12-Mar-24 Payment of Exercise ($163.50K)	Konidaris Tasos Executive Vice President & CFO		Amneal Pharmaceuticals, Inc. - AMRX	38% 380.84K to 527.32K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:54 PM View:	03-Mar-24 Payment of Exercise ($98.62K)	Daly Jason B. SVP, Chief Legal Officer		Amneal Pharmaceuticals, Inc. - AMRX	296% 14.48K to 57.32K	0	0	--	--	Show Txns Hide Txns